Tokyo Tape
Sign in
← Terumo

Quarterly report · Q1

4543.TEDINET S100RML8
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥215.3bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥820.2bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥197.3bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥29.6bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥30.4bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax¥29.8bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥116.1bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥29.7bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥22.5bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥89.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥22.4bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥22.5bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income¥22.4bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥1.67Tat 2023-06-30Cons.Assets IFRS
Total assets¥1.60Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.58Tat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥468.1bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥491.2bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥1.20Tat 2023-06-30Cons.Equity IFRS
Net assets / equity¥1.11Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥1.12Tat 2022-06-30Cons.Equity IFRS
Net assets / equity¥1.01Tat 2022-03-31dCons.Equity IFRS
Equity (owners)¥1.20Tat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.11Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.12Tat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥160.1bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥187.3bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥209.6bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.3bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥11.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥117.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥23.4bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥19.3bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥59.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥16.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥27.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥86.6bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥14.8bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥30.282023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥1192022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥29.612022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥30.272023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥118.952022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥29.62022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio72.0%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio69.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio70.5%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-06-30¥62m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥1.1bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2023-04-01 → 2023-06-30¥40.9bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2023-04-01 → 2023-06-30¥5.9bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2023-04-01 → 2023-06-30¥130.6bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2023-04-01 → 2023-06-30¥26.9bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2023-04-01 → 2023-06-30¥43.7bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2023-04-01 → 2023-06-30¥2.8bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥215.2bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥35.6bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥62m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥198m
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥34.5bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.6bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥116.8bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥28.0bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥46.0bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥4.5bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥197.3bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥36.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 561
ItemContextValueUnit
Selling general and administrative expenses IFRSCurrentYTDDuration80492000000JPY
Other income IFRSPrior1YTDDuration1902000000JPY
Other income IFRSCurrentYTDDuration970000000JPY
Other expenses IFRSPrior1YTDDuration2484000000JPY
Other expenses IFRSCurrentYTDDuration632000000JPY
Operating profit loss IFRSPrior1YTDDuration30427000000JPY
Operating profit loss IFRSCurrentYTDDuration29644000000JPY
Finance income IFRSPrior1YTDDuration515000000JPY
Finance income IFRSCurrentYTDDuration593000000JPY
Finance costs IFRSPrior1YTDDuration1264000000JPY
Finance costs IFRSCurrentYTDDuration444000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-10000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration11000000JPY
Profit loss before tax IFRSPrior1YTDDuration29667000000JPY
Profit loss before tax IFRSCurrentYTDDuration29804000000JPY
Income tax expense IFRSPrior1YTDDuration7268000000JPY
Income tax expense IFRSCurrentYTDDuration7254000000JPY
Profit loss IFRSPrior1YTDDuration22398000000JPY
Profit loss IFRSCurrentYTDDuration22549000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration22398000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration22549000000JPY
Profit loss IFRSPrior1YTDDuration22398000000JPY
Profit loss IFRSCurrentYTDDuration22549000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration29.61
Basic earnings loss per share IFRSCurrentYTDDuration30.28
Diluted earnings loss per share IFRSPrior1YTDDuration29.60
Diluted earnings loss per share IFRSCurrentYTDDuration30.27
Profit loss IFRSPrior1YTDDuration22398000000JPY
Profit loss IFRSCurrentYTDDuration22549000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration6000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-64000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration6000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-64000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration95395000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration84564000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration109000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration207000000JPY
Cost of hedging net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-166000000JPY
Cost of hedging net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-84000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration95338000000JPY
Total of items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration84687000000JPY
Other comprehensive income IFRSPrior1YTDDuration95345000000JPY
Other comprehensive income IFRSCurrentYTDDuration84622000000JPY
Comprehensive income IFRSPrior1YTDDuration117743000000JPY
Comprehensive income IFRSCurrentYTDDuration107172000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration117743000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration107172000000JPY
Comprehensive income IFRSPrior1YTDDuration117743000000JPY
Comprehensive income IFRSCurrentYTDDuration107172000000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember38716000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass